COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated. 2017

Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
Service d'Infectiologie, Centre Hospitalier Universitaire de Nice, Nice, France.

BACKGROUND COPD is a frequent and significant cause of respiratory morbidity in HIV-infected patients despite the control of HIV. We aimed to analyze the factors correlated with COPD in this population to evaluate the existence of specific indicators of vulnerability in this population. RESULTS 623 HIV-infected outpatients were enrolled during one year. This population was characterised by a dedicated questionnaire and electronic patient records. COPD screening was performed according to recommended spirometric criteria. The prevalence of COPD was 9.0%. Age and smoking were independently correlated with COPD (OR, 1.61 per 10 years increase, P = 0.007; OR, 1.28 per 10 pack-year increase, P = 0.003, respectively). Body mass index (BMI) and CD4 cell-count were independently and negatively correlated with COPD (OR, 0.78, P < 0.001; 0R, 0.77 per 100 cell/mm3 increase, P < 0.001, respectively). Among COPD patients, 77% did not know their diagnosis. Five COPD-patients never smoked and 44.2% did not have any respiratory symptoms and so were not eligible to perform a spirometry according to the guidelines. CONCLUSIONS In addition to known risk factors, immune defect through CD4 cell count was independently and strongly correlated with COPD. COPD is largely underdiagnosed and thus unmanaged. However, early management and urgent smoking cessation are essential to improve prognosis. Clinicians' awareness on the particular vulnerability for COPD in HIV-infected patients is crucial. Moreover, indications to perform conventional spirometry to diagnose COPD may include more parameters than tobacco-smoking and respiratory complaints with a particular concern toward patients with a profound CD4 cell count defect.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D013147 Spirometry Measurement of volume of air inhaled or exhaled by the lung. Spirometries
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
January 1993, Medicina,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
October 2008, AIDS research and human retroviruses,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
January 2010, Indian journal of pathology & microbiology,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
May 2009, Current HIV research,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
April 1999, AIDS (London, England),
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
October 1998, International journal of epidemiology,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
December 2004, AIDS (London, England),
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
March 2004, Journal of acquired immune deficiency syndromes (1999),
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
December 1997, International journal of epidemiology,
Karine Risso, and Francine Guillouet-de-Salvador, and Laure Valerio, and Pascal Puglièse, and Alissa Naqvi, and Jacques Durant, and Elisa Demonchy, and Isabelle Perbost, and Eric Cua, and Charles-Hugo Marquette, and Pierre-Marie Roger
December 2004, Revista de saude publica,
Copied contents to your clipboard!